Ex Parte Yu et al - Page 14


             Appeal No. 2004-1761                                                  Page 14                     
             Application No. 10/044,807                                                                        

             forensic analysis, which i[s] undoubtedly a ‘real world’ utility, the presently claimed           
             sequence must in itself be useful.”  Appeal Brief, page 4.  “The fact that forensic               
             biologists use polymorphic markers such as those described by Appellants every day                
             provides more than ample support for the assertion that forensic biologists would also            
             be able to use the specific polymorphic markers described by Appellants in the same               
             fashion.”  Id., page 5.                                                                           
                   This argument is not persuasive.  As their basis for asserting that the disclosed           
             polymorphisms provide utility for the claimed polynucleotides, Appellants cite to “the            
             specification as originally filed, at least page 3, line 15, and from page 11, line 31 to         
             page 12, line 27.”  Appeal Brief, page 4.  We do not find support for the asserted utility        
             in the cited passages.                                                                            
                   The sentence on page 3 that includes line 15 reads as follows:  “The sequences              
             of the present invention are also useful as additional DNA markers for restriction                
             fragment length polymorphism (RFLP) analysis, and in forensic biology.”  Page 11, line            
             31, to page 12, line 27 reads as follows:                                                         
                   The identification and characterization of human genomic clones is helpful                  
                   for identifying polymorphisms (including but not limited to, nucleotide                     
                   repeats, microsatellite alleles, single nucleotide polymorphisms, or coding                 
                   single nucleotide polymorphisms), determining the genomic structure of a                    
                   given locus/allele, and designing diagnostic tests.  For example,                           
                   sequences derived from regions adjacent to the intron/exon boundaries of                    
                   the human gene can be used to design primers for use in amplification                       
                   assays to detect mutations within the exons, introns, splice sites (e.g.,                   
                   splice acceptor and/or donor sites), etc., that can be used in diagnostic                   
                   and pharmacogenomics.                                                                       
                   For example, the present sequences can be used in restriction fragment                      
                   length polymorphism (RFLP) analysis to identify specific individuals.  In                   
                   this technique, an individual’s genomic DNA is digested with one or more                    
                   restriction enzymes, and probed on a Southern blot to yield unique bands                    





Page:  Previous  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  Next 

Last modified: November 3, 2007